Alyssa George on Clinical and Economic Impact of a Eptacog Beta
Alyssa George, Clinical Pharmacist at Henry Ford Health, shared on LinkedIn:
”I am excited to share that my medication use evaluation looking at the use of recombinant factor VIIa has been published in Clinical and Applied Thrombosis and Hemostasis!
For the last two years, we have been working on putting together this manuscript to report our clinical experiences and economical savings with a recombinant factor VIIa formulary interchange from eptacog alfa to eptacog beta.
We successfully used eptacog beta for several labeled and off-label indications, including bleeding and peri-operative management for those with acquired or congenital hemophilia A/B, delta granule storage pool disorder, and intra-operative coagulopathy during cardiac surgery.
We found no incidence of thrombotic events and a low rate of bleeding complications.
For those interested, the article is linked below.
I would like to thank my preceptors Katelyn Sylvester and Dareen Kanaan for all of their hard work on helping me get this manuscript published!”
Read the full article here.
Article: Real World Experience with use of Coagulation Factor VIIa at an Academic Medical Center
Authors: Alyssa George, Katelyn Sylvester, Dareen Kanaan, Prabashni Reddy, John Fanikos, Jean Connors, Nathan Connell
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 23, 2026, 16:04Monia Ezzalfani: Advancing Patient-Centered Care in Hemophilia A and B
-
Sep 23, 2026, 15:49Bilge Başak: How Activated PRP Modulates Osteoarthritic Chondrocyte Function
-
Sep 23, 2026, 14:50Mbonjo Bitsie Dora: Strengthening Sickle Cell Care Through Education, Awareness and Innovation
-
Sep 23, 2026, 13:58The New B12 Diagnostic Algorithm: From Serum Cobalamin to Functional Deficiency
-
Sep 23, 2026, 13:56Noha Soror: Preparing for Hematology and Medical Oncology Board Certification
-
Sep 23, 2026, 13:46Ugochi Ogu: What Can Platelet Proteomics Reveal about Pain and Neurocognitive Vulnerability in Sickle Cell Disease?
-
Sep 23, 2026, 13:42Melissa Hollo: Connecting Obesity and Anemia for Earlier Maternal Risk Intervention
-
Sep 23, 2026, 13:16Beverley Hunt: Advances in Haemostatic Management of Postpartum Haemorrhage
-
Sep 23, 2026, 13:13Ioanna Mela: Recruiting a Research Associate on DNA nanotechnology